5.32
+0.14(+2.70%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
1019
First IPO Date
October 30, 2009
| Name | Title | Pay | Year Born |
| Dan Cui | Deputy GM, Secretary & General Counsel | 0 | 1980 |
| Rongzhao Qiu | General Manager | 0 | 1994 |
| Song Lin | Deputy GM & Director | 0 | 1973 |
| Xue Feng Leng | Deputy GM & Vice Chairman | 0 | 1972 |
| Ruoyue Wang | Deputy General Manager | 0 | 1959 |
| Wen Lai | Financial Director | 0 | 1974 |
Chongqing Lummy Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products in China. The company provides tumor, antibacterial, antiviral, and antifungal, as well as liver disease auxiliary, endocrinology system, and Chinese patent drugs; digestive system, immune system, blood system, cardiovascular system, and nervous system drugs; electrolyte and acid-base products; balance and nutritional products; and base large infusion products, American ginseng systems, and active pharmaceutical ingredients. Chongqing Lummy Pharmaceutical Co., Ltd. was founded in 1999 and is based in Chongqing, China.
